We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+8.98%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.5B
AUM Growth
+$1.83B
Cap. Flow
+$876M
Cap. Flow %
6.02%
Top 10 Hldgs %
16.47%
Holding
2,314
New
674
Increased
480
Reduced
478
Closed
662

Top Buys

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$137M
2
HD icon
Home Depot
HD
+$120M
3
AMZN icon
Amazon
AMZN
+$96.2M
4
EBAY icon
eBay
EBAY
+$85.4M
5
A icon
Agilent Technologies
A
+$79.9M

Top Sells

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$107M
2
DHR icon
Danaher
DHR
+$78M
3
TMO icon
Thermo Fisher Scientific
TMO
+$71M
4
YUM icon
Yum! Brands
YUM
+$61.4M
5
CELG
Celgene Corp
CELG
+$57.6M

Sector Composition

Rank Sector Weight
1 Healthcare 23.89%
2 Consumer Discretionary 20.94%
3 Technology 12.55%
4 Financials 6.81%
5 Industrials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RUTH
2176
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
-59,605
Closed -$1.22M
MAXR
2177
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
-242,931
Closed -$1.85M
AUY
2178
DELISTED
Yamana Gold, Inc.
AUY
-51,080
Closed -$162K
MYOV
2179
DELISTED
Myovant Sciences Ltd.
MYOV
-70,217
Closed -$365K
CNCE
2180
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
-3,894
Closed -$23K
UMPQ
2181
DELISTED
Umpqua Holdings Corp
UMPQ
-273,133
Closed -$4.5M
COUP
2182
DELISTED
Coupa Software Incorporated
COUP
-3,049
Closed -$395K
AVYA
2183
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
-125,154
Closed -$1.28M
SPNE
2184
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
-1,100
Closed -$13K
CLVS
2185
DELISTED
Clovis Oncology, Inc.
CLVS
-63,476
Closed -$249K
PZN
2186
DELISTED
Pzena Investment Management, Inc. Class A
PZN
-18,316
Closed -$163K
CVET
2187
DELISTED
Covetrus, Inc. Common Stock
CVET
-2,797
Closed -$33K
DRE
2188
DELISTED
Duke Realty Corp.
DRE
-68,037
Closed -$2.31M
USAK
2189
DELISTED
USA Truck Inc
USAK
-146,306
Closed -$1.18M
TUFN
2190
DELISTED
Tufin Software Technologies Ltd.
TUFN
-2,448
Closed -$40K
CDR
2191
DELISTED
Cedar Realty Trust, Inc
CDR
-34,082
Closed -$675K
NTUS
2192
DELISTED
Natus Medical Inc
NTUS
-35,839
Closed -$1.14M
PTE
2193
DELISTED
PolarityTE, Inc. Common Stock
PTE
-715
Closed -$58K
EPAY
2194
DELISTED
Bottomline Technologies Inc
EPAY
-165,513
Closed -$6.51M
PBCT
2195
DELISTED
People's United Financial Inc
PBCT
$0 ﹤0.01%
+9
New +$147
VNE
2196
DELISTED
Veoneer, Inc.
VNE
-4,062
Closed -$61K
SUNS
2197
DELISTED
SLR Senior Investment Corp. Common Stock
SUNS
-2,425
Closed -$43K
KRA
2198
DELISTED
Kraton Corporation
KRA
-4,461
Closed -$144K
FMBI
2199
DELISTED
First Midwest Bancorp Inc/IL
FMBI
-6,206
Closed -$121K
NFH
2200
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
-243,620
Closed -$2.48M

Similar funds

Marshall Wace's Q4 2019 Portfolio in Review

As of Q4 2019, Marshall Wace held 2,314 positions worth $14.5B, up 14% from $12.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $876M of net new capital in Q4 2019, opening 674 new positions and adding to 480 existing holdings. Its largest new stake was Procter & Gamble: 356,181 shares worth $44.5M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was McDonald's, an estimated $107M trimmed.

  • Marshall Wace's largest Q4 2019 buy was Procter & Gamble: 356,181 shares worth $44.5M.
  • Marshall Wace added most to PayPal in Q4 2019, an estimated $137M increase.
  • Marshall Wace's biggest Q4 2019 reduction was McDonald's, cutting an estimated $107M.
  • Marshall Wace fully exited Yum! Brands in Q4 2019, selling an estimated $61.4M.
  • Marshall Wace's ten largest holdings make up 16% of its $14.5B portfolio in Q4 2019.
  • Marshall Wace opened 674 new positions and closed 662 in Q4 2019.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $14.5B.

Based on Marshall Wace's 13F filing for Q4 2019, filed 14 Feb 2020.